Non-Invasive Glucose Monitoring Devices Market: By Technology (Raman Spectroscopy, MIR/NIR (Mid/Near Infrared Spectroscopy), Optical Coherence Tomography, Occlusion Spectroscopy, Thermal Emission Spectroscopy, Impedance/Dielectric Spectroscopy, Photoacoustic Spectroscopy, Electromagnetic, Fluorescence, Polarimetry), By Modality ( Wearable, Non-Wearable), By End User (Hospitals, Diagnostic centres, Home Care, Ambulatory surgical centres), By Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Non-Invasive Glucose Monitoring Devices Market size was valued at USD 15 million in 2021 and is expected to reach USD 94.1 million by 2028 growing at a CAGR of 30% from 2022-2028. The non-Invasive Glucose Monitoring Devices Market has many market players and highly fragmented. Market players invest on product innovations to sustain their position in the market. In addition collaborations and acquisitions are key strategies used by market players to increase their market share. For example in 2014, NovioSense had created smaller than usual electrochemical sensor that empower non-obtrusive glucose checking and is equipped for identifying glucose focus in human tears. Technological progressions and expanding FDA endorsement for observing gadgets is required to give lucrative development chances to showcase players in coming years. For example, the advancement of new checking gadgets, for example, GlucoTrack which is a non-obtrusive blood glucose screen that clasps to ear cartilage consequently disposing of the requirement for day by day finger pricks.Systemic Lupus Erythematosus (SLE) is an immune system infection that influences different organ frameworks of the body, and its side effects go from general disquietude to genuine, CNS and renal indications. Presently, there are restricted treatment choices accessible to treat the condition. Corticosteroids, hydroxychloroquine, and ordinary immunosuppressant are the pillar of treatment for SLE. Non-Invasive Blood Glucose Monitoring Devices use a painless approach to track a patient's glucose level on a continuous basis. Non-invasive blood glucose monitoring devices require fewer finger sticks and allow data to be easily transferred and shared for further analysis. Patients can use these gadgets at home to monitor their blood glucose levels. Noninvasive glucose monitoring reduces the necessity for unpleasant pricking, which increases the risk of infection and the amount of damage to finger tissue.

Non Invasive Glucose Monitoring Devices Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Non-Invasive Glucose Monitoring Devices Market Dynamics

Non-Invasive Glucose Monitoring Devices market is driven by high incidence of diabetes worldwide. According to WHO, prevalence of diabetes among adults over 18 years of age to have risen from 4.7% in 2012 to 8.5% by 2014. It also projects high blood glucose level and diabetes to be the 7th leading cause of death in 2030. In addition technological advancements in glucose measuring devices such as evolution of continuous glucose monitoring devices are propelling the growth of Non-Invasive Glucose Monitoring Devices market. Furthermore increase in demand for portable self-glucose measuring devices, increase in R&D investment and government funding in prevention and treatment of diabetes are expected to bolster the Non-Invasive Glucose Monitoring Devices globally

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Non Invasive Glucose Monitoring Devices Market Segmentation

  • Raman Spectroscopy
  • MIR/NIR (Mid/Near Infrared Spectroscopy)
  • Optical Coherence Tomography
  • Occlusion Spectroscopy
  • Thermal Emission Spectroscopy
  • Impedance/Dielectric Spectroscopy
  • Photoacoustic Spectroscopy
  • Electromagnetic
  • Fluorescence
  • Polarimetry
  • Wearable
  • Non wearable
End User
  • Hospitals
  • Diagnostic centres
  • Home Care
  • Ambulatory surgical centres

Frequently Asked Questions

The non-invasive glucose monitoring devices market is projected to expand at a CAGR of 30% during the forecast period.  

Abbott Laboratories (U.S.), ARKRAY, Inc. (Japan), Bayer AG (Germany), Dexcom, Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland)

North America is the fastest-growing region for non-invasive glucose monitoring devices market

  • Abbott Laboratories (U.S.)
  • ARKRAY, Inc. (Japan)
  • Bayer AG (Germany)
  • Dexcom, Inc. (U.S.),
  • Hoffmann-La Roche Ltd (Switzerland)
  • Johnson & Johnson (U.S.)
  • Medtronic plc (U.S.)
  • Nipro Diagnostics, Inc. (U.S.)
  • Terumo Medical Corporation (U.S.)